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ABSTRACT
Objective: The authors evaluated the use of
conditional cash transfers as an HIV and sexually
transmitted infection prevention strategy to incentivise
safe sex.
Design: An unblinded, individually randomised and
controlled trial.
Setting: 10 villages within the Kilombero/Ulanga
districts of the Ifakara Health and Demographic
Surveillance System in rural south-west Tanzania.
Participants: The authors enrolled 2399 participants,
aged 18e30 years, including adult spouses.
Interventions: Participants were randomly assigned
to either a control arm (n¼1124) or one of two
intervention arms: low-value conditional cash transfer
(eligible for $10 per testing round, n¼660) and high-
value conditional cash transfer (eligible for $20 per
testing round, n¼615). The authors tested participants
every 4 months over a 12-month period for the
presence of common sexually transmitted infections.
In the intervention arms, conditional cash transfer
payments were tied to negative sexually transmitted
infection test results. Anyone testing positive for
a sexually transmitted infection was offered free
treatment, and all received counselling.
Main outcome measures: The primary study end
point was combined prevalence of the four sexually
transmitted infections, which were tested and reported
to subjects every 4 months: Chlamydia trachomatis,
Neisseria gonorrhoeae, Trichomonas vaginalis and
Mycoplasma genitalium. The authors also tested for
HIV, herpes simplex virus 2 and syphilis at baseline
and month 12.
Results: At the end of the 12-month period, for the
combined prevalence of any of the four sexually
transmitted infections, which were tested and reported
every 4 months (C trachomatis, N gonorrhoeae, T
vaginalis and M genitalium), unadjusted RR for the
high-value conditional cash transfer arm compared to
controls was 0.80 (95% CI 0.54 to 1.06) and the
adjusted RR was 0.73 (95% CI 0.47 to 0.99).
Unadjusted RR for the high-value conditional cash
transfer arm compared to the low-value conditional
cash transfer arm was 0.76 (95% CI 0.49 to 1.03) and
the adjusted RR was 0.69 (95% CI 0.45 to 0.92). No
harm was reported.
ARTICLE SUMMARY
Article focus
- Existing prevention strategies have had a limited
impact on the trajectory of the HIV/AIDS
epidemic.
- Conditional cash transfers have been used
successfully in a variety of settings to promote
activities that are beneﬁcial to the participants,
such as school participation or health check-ups
for children.
- This trial asks whether conditional cash transfers
can be used to prevent people from engaging in
activities that are harmful to themselves and
others, such as unsafe sex.
Key messages
- We designed and evaluated a novel intervention
that tests for risky sexual behaviour repeatedly
over short time intervals, reinforcing learning
about safer behaviour with cash transfer incen-
tives conditional on testing negative for a set of
curable sexually transmitted infections (STIs).
- After 12 months, the results from the adjusted
model showed a signiﬁcant reduction in the
combined point prevalence of the four curable
STIs tested every 4 months by nucleic acid
ampliﬁcation tests in the group that was eligible
for the $20 payments, but no such reduction was
found for the group receiving the $10 payments.
- The results suggest that conditional cash trans-
fers used to incentivise safer sexual practices are
a potentially promising new tool in HIV and STIs
prevention. Additional larger study would be
useful to clarify the effect size, to calibrate the
size of the incentive and to determine whether
the intervention can be delivered cost effectively.
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Open Access ResearchConclusions: Conditional cash transfers used to incentivise safer
sexual practices are a potentially promising new tool in HIV and
sexually transmitted infections prevention. Additional larger study
would be useful to clarify the effect size, to calibrate the size of the
incentive and to determine whether the intervention can be delivered
cost effectively.
Trial registration number: NCT00922038 ClinicalTrials.gov.
INTRODUCTION
Innovative solutions for AIDS prevention are desperately
needed. The Joint United Nations Programme on HIV/
AIDS reported that ﬁve people are infected for every two
placed on treatment, and, in 2009, approximately 2.8
million people were newly infected.
1 Large-scale behav-
iour change interventions aimed at promoting safer
sexual practices have proven less effective and more
unreliable at stemming the tide of the epidemic than
hoped.
23It has been far more difﬁcult than was ﬁrst
anticipated to persuade high-risk populations to adopt
safer sexual behaviours and practices that serve their
longer term interests.
Conditional cash transfer programmes have become an
increasingly popular approach for incentivising socially
desirable behavioural change.
4 The principle of condi-
tionalitydmaking payments contingent, for example, on
a minimal level of schooling attendance or preventive
care useddistinguishes conditional cash transfer
programmes from more traditional means tested social
programmes. The evaluation of conditional cash transfer
programmes has shown that they can be effective at
raising consumption, education and preventive health-
care,
5 as well as actual health outcomes.
6 Similarly,
‘contingency management’ approaches have shown
important substance abuse reductions by conditioning
rewards on negative tests for drug or alcohol use.
7
In the context of the staggering social, economic and
human costs of the AIDS epidemic in sub-Saharan
Africa, it is perhaps not as great a leap as it would ﬁrst
appear to apply the logic of conditional cash transfers to
the private arena of human sexuality with the aim of
incentivising safer sexual practices among high-risk
populations. Numerous studies have documented the
responsiveness of sexual behaviour to incentives, such as
sex workers willing to forego condoms when clients pay
extra,
8 and increases in transactional sex in the face of
household ﬁnancial difﬁculties.
9 Economic theory
suggests several pathways through which risky sexual
behaviours could be reduced by a conditional cash
transfer programme that conditions payment on nega-
tive sexually transmitted infections (STIs) tests. Standard
theory predicts that the incentives could operate by
raising the implicit price of unsafe sex (risking losing the
conditional cash transfer) or by bringing the rewards of
risk avoidance much closer to the present (eg, a condi-
tional cash transfer within weeks may be more powerful
for some people than the spectre of developing AIDS
many years in the future) or both. If the conditional cash
transfer was sufﬁciently large, then this higher income
could also relieve economic pressures on young women
to engage in transactional sex; but even if incentives
were small, recent behavioural economics research
suggests that regular reminders of this new frame for
viewing sexual behaviour could still ‘nudge’ individuals
to overcome inertia and extricate themselves from
unduly risky sexual relationships.
10 In Malawi, small
ﬁnancial incentives have already been shown to increase
the uptake of HIV testing and counselling.
11 In the only
prior study similar to ours, a follow-on Malawi interven-
tion promised a single cash reward in 1 year’s time for
individuals who remained HIV negative, but this design
had no measurable effect on HIV status.
12 By contrast,
we used the above theory to design and evaluate a novel
intervention that tests for risky sexual behaviour
repeatedly over shorter time intervals, reinforcing
learning about safer behaviour with conditional cash
transfer incentives each time.
METHODS
Trial design
This study is an unblinded, individually randomised and
controlled trial. It has three separate armsda control
arm with an allocation ratio of 50% and two intervention
arms (low-value conditional cash transfer and high-value
conditional cash transfer), with an allocation ratio of
25% each. No important changes to methods were
implemented after trial commencement.
Participants
Inclusion criteria consisted of males and females, aged
18e30 years (and spouses starting at age 16 years and
potentially older than 30 years), residing in one of 10
study villages within the Kilombero/Ulanga districts of
the Ifakara Health and Demographic Surveillance
ARTICLE SUMMARY
Strengths and limitations of this study
- This paper reports the results of a novel approach for HIV and
STI prevention.
- Our study methodology is rigorous, and the results are likely to
advance a global conversation about economic approaches to
HIV/STI prevention.
- Our main outcome measure is the combined point prevalence
of four STIs repeatedly tested by nucleic acid ampliﬁcation
tests over the course of the year and which have been
incontrovertibly linked to risky sexual activity. These biological
outcomes, however, cannot be used to infer the relative
importance of STI treatment seeking behaviour versus other
behaviour changes, such as increased condom use or reducing
riskiness of partners.
- The results reported in this study are limited to a 12-month
experiment and cannot address the sustainability of improve-
ments in STI outcomes over a longer period, particularly after
the conditional cash transfers have been discontinued.
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13 in south-west Tanzania. The villages consisted
of eight rural villages and two semi-urban neighbour-
hoods in Ifakara town, with participants evenly distrib-
uted across the villages. On average across the 10
villages, approximately 20% of the 18e30 old residents
were enrolled in the study. There were three exclusion
criteria: being pregnant at the time of registration,
having the intention to permanently migrate out of the
Ifakara Health and Demographic Surveillance System
area within the next year and unwillingness to partici-
pate if assigned to the control arm. HIV-positives were
eligible for enrolment.
Interventions
The intervention arm was divided into two subarmsd
a low-value conditional cash transfer arm eligible for up
to $30 over the course of the study (10000 Tanzanian
shillings or approximately $10 per testing round) and
a high-value conditional cash transfer arm eligible for up
to $60 (20000 Tanzanian shillings or approximately $20
per testing round). Those amounts were determined
based on focus-group discussions in neighbouring
villages conducted before the intervention started,
balancing sufﬁcient incentive levels against concerns
about scalability and potential coercion. All participants
were tested for STIs at baseline and then every 4 months
for 1 year. Participants in the two intervention arms were
eligible to receive conditional cash transfer incentive
payments if they tested negative for curable STIs at the
4-, 8- and 12-month testing rounds. STIs tested at all
these incentivised rounds were Chlamydia trachomatis,
Neisseria gonorrhoeae, Trichomonas vaginalis and Myco-
plasma genitalium, which are transmitted through
unprotected sexual contact and therefore serve as
a proxy for risky sexual behaviour as well as vulnerability
to HIV infection.
14e17
Individuals in the conditional cash transfer arms were
not eligible for the cash award at the 4-, 8- and 12-month
testing rounds if they tested positive for any of the
following: C trachomatis, N gonorrhoeae and T vaginalis.
Those converting from negative at baseline to positive at
12 months for syphilis or herpes simplex virus 2 were
also ineligible to receive the 12-month conditional cash
transfer. HIV testing was conducted at baseline and
month 12, but payments were not conditioned on those
results because of local ethical sensitivities. M genitalium
results did not affect conditional cash transfer eligibility
because there is some uncertainty around transmission
pathways; however, it was included in the combined
prevalence measure used as primary outcome to increase
statistical power. Individuals in the intervention arms
testing positive for any of the conditioned curable STIs
did not receive the conditional cash transfer but were
eligible to continue as a study participant in subsequent
rounds after having been treated and cured of the
infection. Individuals in the control arm were not
eligible for conditional cash transfer, but all other study
procedures were identical between the control and
intervention arms. Anyone testing positive for a STI
(regardless of arm) was offered counselling and free STI
treatment (for self and partners) through health facili-
ties of the District Ministry of Health serving the
research communities. Individual pre-test and post-test
counselling was provided to study enrollees at each
testing interval, following Tanzania national testing
guidelines. In addition, monthly group counselling
sessions emphasising relationship skills training adapted
from a subset of the Stepping Stones curriculum
18 were
also made available to all study participants in all villages
but were not mandatory.
Outcomes
The biological markers used in the study were selected
both due to their likely prevalence levels in the study
population and due to their status within the epidemi-
ological literature as reasonable proxies for risky sexual
behaviour. The primary outcome measure, as deﬁned in
the study protocol, is the round-speciﬁc combined point
prevalence of the four STIs that were regularly testedd
C trachomatis, N gonorrhoeae, T vaginalis and M genitaliumd
at months 4, 8 and 12. This measure of combined point
prevalence was constructed at study design to ensure
sufﬁcient power to detect differences in the control and
treatment groups in response to the conditional cash
transfer intervention. For logistical reasons, M genitalium
testing was not conducted at baseline. We also tested for
HIV, herpes simplex virus 2 and syphilis at baseline and
month 12.
All STI testing was conducted by the Ifakara Health
Institute microbiology laboratory in Ifakara. All test
results were available within 7e10 days and were
returned to participants the following week. Ten per
cent of all samples, and all positives, were sent to the
University of California Chlamydia Laboratory for
conﬁrmation analysis (quality control).
Specimens for chlamydia, gonorrhoea, trichomonas
and M genitalium were collected by a self-administered
vaginal swab for women. Men provided a ‘ﬁrst-catch
urine’ (about 20e30 ml) sample. Specimen collection
among women was always observed by a nurse at the
testing station. For men, the specialised receptacle used
to collect a urine sample was provided only after drop-
ping off personal belongings upon checking into the
testing section of the study station. Men were asked to
urinate into the study receptacle in the vicinity of the
study station. Detection used GenProbe Aptima (GenP-
robe Inc, San Diego, California, USA) nucleic acid
ampliﬁcation tests.
To test for HIV, herpes simplex virus 2 and syphilis,
a single venous blood sample of approximately 5e10 ml
was collected from each participant at baseline and
month 12. For herpes simplex virus 2, we used the Focus
HerpeSelect HSV-2 ELISA IgG assay (Focus Technolo-
gies, Cypress, California, USA) to detect serum anti-
bodies. Treponema pallidum was identiﬁed using rapid
plasma reagin with reactive tests conﬁrmed by T pallidum
particle agglutination assay. Active syphilis was deﬁned as
rapid plasma reagin+/T pallidum particle agglutination
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screening results (SD Bioline HIV-1/2 3.0; Standard
Diagnostics, INC., Kyonggi-do, Korea), conﬁrmation of
positives (Determine HIV-1/2; Inverness Medical
Japan Co, Ltd, Tokyo, Japan), and tie-breaking (Uni-
Gold HIV, Trinity Biotech plc. Bray, Ireland).
Sample size
Early study planning had initially assumed a sample size
of 3000, which would have provided improved power for
gender subgroup analysis in our main comparisons, but
due to logistical ﬁeldwork constraints the recruited
sample size was reduced to approximately 2400. We
present here the ex-post power calculations at this actual
recruited sample size and actual infection rates, based
on a comparison of combined STI prevalence rates of
12% between two equal-sized study arms for a single
post-treatment measurement of proportions controlling
for one baseline measure and assuming a two-sided
alternative hypothesis. We calculated that a total sample
size of 2400 individuals would be sufﬁcient to provide at
least 90% power to detect a one-third intervention-
related reduction in STI point prevalence (signiﬁcant at
the 5% level) in both intervention arms combined. This
sample size would also retain at least 80% power to
detect a reduction in a single intervention arm (eg, the
high-value conditional cash transfer arm) compared to
the control arm, and if the prevalence was assumed to be
as high as 20%, then this power rises to over 90%.
Subgroup analysis by gender would not be powered at
the 80% level for our main comparison of the high-value
conditional cash transfer arm against controls assuming
a 12% prevalence level, although it would retain
approximately 90% power when comparing the
combined arms against the control arm assuming 20%
prevalence.
Randomisation
Individual-level randomisation took place at the study
station after baseline interview and testing, with partici-
pants selecting coloured balls from an opaque bag. The
randomisation took place in public view and in two
stages with participants ﬁrst randomly selecting one of
four balls to determine their allocation to the interven-
tion or the control arm. In order to study potential peer-
effects, in randomly selected subvillages, the probably of
selection in the intervention arm was 75% (three balls
out of four) and in the other subvillages, it was 25% (one
ball out of four); based on the distribution of partici-
pants across subvillages, we thus expected 48% of the
overall sample to be randomised into the control arm.
Participants randomised into the intervention arm were
further invited to choose one of two balls from a second
bag determining in which of the two intervention arms
(low-value conditional cash transfers and high-value
conditional cash transfers) they would be allocated.
These highly transparent procedures were deemed
necessary for acceptability of randomisation in a popu-
lation with limited formal education. Participants were
not blinded to arm assignment since awareness of their
eligibility for the conditional cash transfer was a critical
component of the intervention.
Spousal pairs were assigned the same intervention arm
and the protocol prescribed for randomisation to occur
after both spouses had enrolled.
Statistical methods
Each individual was coded as per their initial rando-
mised assignment as per an intent-to-treat design.
However, individuals who were not present at any given
round were treated as missing and dropped from the
analysis for that round due to lack of outcome data. We
report sample means at baseline to verify the balance
across the three study arms. Unadjusted outcomes at the
three follow-up rounds are reported using RRs, that is,
the probability of being positive for any STI in the
intervention arm, divided by the probability of being
positive for any STI in the control arm. RRs are calcu-
lated from logistic regressions using the margins and
nlcom post-estimation commands in the Stata V.12 statis-
tical software package. We further report adjusted
outcomes using RRs to account for residual variation
across arms after randomisation. Adjustments have been
made for standard socioeconomic variables, such as
gender, education, age, marital status, income, socio-
economic status, subvillage and baseline STI status. Age
and income are continuous variables, while the other
adjustment variables are categorical. We cluster SEs both
at the household and at subvillage levels, accounting for
the possible correlation within couples and the variation
in selection probability at that subvillage level. We
present a subgroup analysis by gender. We used Stata
V.12.1 (Stata Corp) for statistical analysis.
RESULTS
Participant ﬂow
A total of 5370 individuals were randomly selected from
the Ifakara Health and Demographic Surveillance System
sample (ﬁgure 1). Eight hundred and sixty-four (16.1%)
of those individuals were not found, six (0.1%) had died
and 344 (6.4%) had migrated. Fieldworkers assessed for
eligibility 4156 individuals: 173 (4.2%) did not meet the
inclusion criteria, among them 35 (0.8%) were not in the
study age range and 138 women (3.3%) were currently
pregnant. Of those eligible, 133 (3.3%) explicitly refused
to participate in the study and 168 (4.2%) declined for
other reasons. All others (3682) were given an invitation
to come to a study station the following week: 2409
(65.4%) registered for the study and were randomised
into one of the three study arms, while 1273 did not
come to the study station for registration.
Of the 2409 registered participants, 1124 (46.7%) were
randomly allocated to the control arm. Among the
participants, 1285 were randomly selected, in a ﬁrst
stage, to one of the two conditional cash transfer arms:
615 (25.5%) were randomly assigned in the high-value
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low-value conditional cash transfer arm. Ten (0.4%)
individuals assigned to the intervention arms were
intentionally dropped from the analysis since they failed
to be further randomised in one of the two subarms. In
the control arm, 967 were tested and interviewed at
round 2 (attrition 14%), 983 (attrition 12.5%) at round
3 and 1039 (attrition 7.6%) at round 4. In the high-value
conditional cash transfer arm, 570 were tested and
interviewed at round 2 (attrition 7.3%), 567 (attrition
7.8%) at round 3 and 585 (attrition 4.9%) at round 4. In
the low-value conditional cash transfer arm, 568 were
tested and interviewed at round 2 (attrition 13.9%), 567
(attrition 14.1%) at round 3 and 618 (attrition 6.4%) at
round 4. Overall, attrition was lower at round 4 because
the ﬁeld team made extensive additional effort to
contact and interview attriters. Symptomatic individuals
in all study arms were particularly encouraged to come
to the study station in order to receive free STI treat-
ment. Attrition was not predicted by any of the baseline
STI results, except that HIV-positive individuals at base-
line were more likely to be lost to follow-up, despite the
fact the participants were clearly told that HIV status
would not affect eligibility for conditional cash transfers.
Recruitment
Recruitment and baseline data collection took place
from 10 February to 9 April 2009. The second, third and
fourth rounds of interviews and testing took place from
9 June to 15 August 2009, 29 September to 5 December
2009 and 16 February to 1 May 2010, respectively. The
conditional cash transfer intervention was stopped after
1 year, following the protocol.
Process
The intervention was well accepted and accessed by the
study participants as indicated in the participant ﬂow
and the low attrition numbers. Furthermore, study
participants randomised into the conditional cash
transfer arms declared that the ﬁnancial incentives
motivated them to modify their behaviour. In the high-
value conditional cash transfer arm, 317 (59.0%)
Figure 1 Participant ﬂow
diagram.
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change their behaviour and 67 (12.5%) stated that it
motivated them ‘somewhat’. In the low-value conditional
cash transfer arm, those numbers are 194 (37.4%) for
‘very much’ and 107 (20.6%) for ‘somewhat’.
Baseline data
Table 1 describes the baseline characteristics of the
participants by study arm. The prevalence of the six STIs
tested at baseline was distributed similarly across arms.
Participants were also similar according to gender and
education. However, individuals in the two intervention
arms had slightly lower self-reported socioeconomic
status, and individuals in the low-value conditional cash
transfer arm also had a higher income.
We veriﬁed that there was no deviation from protocol
that could have led to differential secondary spousal
enrolment across arms: 604 out of the 2399 participants
were spouses who joined the study after their spouse was
initially invited. They were distributed as follows: 279 out
of 1124 (24.8%) in the control arm, 156 (25.4%) out of
615 in the high-value cash arm and 169 (25.6%) out of
660 in the low-value cash arm. Tests for statistical
differences with the control arm yielded p values of
0.673 for the high-value conditional cash transfer arm
and 0.742 for the low-value conditional cash transfer
arm, so differences across the three study arms in the
percentage of spouses joining the study are minimal and
not statistically signiﬁcant.
Numbers analysed
Except for the 10 (0.4%) individuals who failed to be
assigned to either the high or low-value conditional cash
transfer arm, all participants tested and interviewed at
the respective rounds were included in the analysis
(refer to the sample sizes in tables 1 and 2). The
reductions in sample size from the unadjusted (table 2)
to the adjusted analysis (table 3) were from 2105 to 2077
at round 2, from 2117 to 2092 at round 3 and from 2242
to 2211 at round 4 due to missing data on covariates in
the logistic regression model (table 2 results are similar
when using the smaller samples from table 3).
Outcomes and estimation
Table 2 presents the unadjusted RR ratios compared to
the control group. At months 4, 8 and 12 when the
outcome is the combined point prevalence of the four
curable STIs tested every 4 months by nucleic acid
ampliﬁcation tests (columns 1e3), the RRs are not
statistically different at the 5% signiﬁcance level. At
month 12, the number of positives was 57 (9.7%) in the
high-value conditional cash transfer arm, while it was 79
(12.8%) in the low-value conditional cash transfer arm
and 126 (12.1%) in the control group. At month 12, this
unadjusted analysis estimated a reduction in the RR of
those four curable STIs for the high-value conditional
cash transfer arm of 20% (95% CI 6% increase to 46%
reduction). The RRs were also not statistically different
at the 5% signiﬁcance level in column 4 for the combi-
nation of syphilis prevalence and new cases of HIV and
herpes simplex virus 2. Those three STIs were detected
by serology performed only at baseline and round 4. For
the combined point prevalence of chlamydia, gonor-
rhoea, trichomonas, M genitalium at month 12, the
unadjusted RRs are not statistically different than 1 at
5% signiﬁcance level when men and women are
considered separately (columns 5 and 6). At month 12,
for the combined point prevalence of the four curable
Table 1 Summary statistics at baseline, by arm
(1) (2) (3)
Variables Control High-value CCT Low-value CCT
Female 561 (49.9%) 314 (51.1%) 329 (49.9%)
Age 27.2 (5.6) 27.6 (5.4) 27.6 (5.7)
Education
None 139 (12.4%) 70 (11.4%) 79 (12.0%)
Primary 863 (76.8%) 482 (78.4%) 660 (78.3%)
Secondary 122 (10.9%) 63 (10.2%) 64 (9.7%)
Married 842 (75.0%) 474 (77.1%) 476 (72.7%)
Low SES 582 (51.8%) 344 (55.9%) 377 (57.2%)
Yearly income 239311 (425091) 257017 (531370) 283218 (534399)
Chlamydia 21 (1.9%) 15 (2.4%) 16 (2.4%)
Gonorrhoea 8 (0.7%) 8 (1.3%) 6 (0.9%)
Trichomonas 130 (11.6%) 88 (14.3%) 79 (12.0%)
Herpes simplex virus 2 380 (33.9%) 226 (36.8%) 225 (34.2%)
Syphilis 17 (1.5%) 8 (1.3%) 15 (2.3%)
HIV 41 (3.7%) 17 (2.8%) 27 (4.1%)
N 1124 615 660
Data are represented in means (SD) or numbers (%).
Yearly income in Tanzanian Shillings (Tsh).
At baseline, 1000 Tsh ¼ approximately 1US$.
Low SES corresponds to the lowest two ranks on a self-reported socioeconomic status scale from 1 to 7.
CCT, conditional cash transfer.
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justed RR for the high-value conditional cash transfer
arm compared to the low-value conditional cash transfer
arm was 0.76 (95% CI 0.49 to 1.03) and was 0.56 (95% CI
0.26 to 0.87) for men only.
Table 3 presents results from adjusted regressions.
Adjustments have been made for gender, education, age,
marital status, income, socioeconomic status, subvillage
and baseline STI status. At months 4 and 8 (columns 1
and 2), the combined prevalence of the four STIs tested
by nucleic acid ampliﬁcation tests is shown to have RRs
lower than 1 for the two conditional cash transfer arms
compared to the control arm, but not signiﬁcantly so.
However, at month 12 (column 3) for the combined
prevalence of the STIs tested by nucleic acid ampliﬁca-
tion tests, the adjusted model estimated a 27% reduction
in the RRs for the high-value conditional cash transfer
arm compared to the control arm (95% CI 1% to 53%
reduction), while the RR is not statistically different from
1 for the low-value conditional cash transfer arm. At
month 12, for the three STIs detected by serology
(without having been tested at months 4 and 8), the RR
for the low-value conditional cash transfer arm is 0.82
(column 4) but is not signiﬁcantly lower than the control
arm (95% CI 0.60 to 1.03). In a subgroup analysis by
gender (columns 5 and 6), for the four STIs tested by
nucleic acid ampliﬁcation tests, the RRs for the high-
value conditional cash transfer arm are 0.68 for men and
0.76 for women. Those two RRs are not signiﬁcantly
different from each other (as conﬁrmed by test of
interaction between gender and arm, where an interac-
tion term for woman was not signiﬁcant for either
conditional cash transfer arm (p values 0.648 for high-
value cash transfer arm and 0.391 for low-value cash
transfer arm) and is not signiﬁcantly lower than 1 at the
5% level. At month 12, for the combined point preva-
lence of the four STIs tested by nucleic acid ampliﬁca-
tion tests, adjusted RR for the high-value conditional
cash transfer arm compared to the low-value conditional
cash transfer arm was 0.69 (95% CI 0.45 to 0.92) and was
0.52 (95% CI 0.23 to 0.80) for men only.
DISCUSSION
After 12 months, the adjusted results showed a signiﬁ-
cant reduction in the combined point prevalence of the
four curable STIs tested every 4 months by nucleic acid
ampliﬁcation tests in the group that was eligible for the
$20 quarterly payments, but no such reduction was
found for the group receiving the $10 quarterly
payments. Such results were not found at earlier rounds
nor for unadjusted results. Furthermore, the impact of
the conditional cash transfers did not differ between
men and women.
Limitation
Our main outcome measure is the combined point
prevalence of four STIs repeatedly tested by nucleic acid
ampliﬁcation tests over the course of the year and which
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These biological outcomes, however, cannot be used to
infer the relative importance of STI treatment seeking
behaviour versus other behaviour changes, such as
increased condom use or reducing riskiness of partners.
Furthermore, the lack of a clear result on the combined
measure for the three STIs that were detected by
serology only at baseline and month 12 (this measure
primarily reﬂects herpes simplex virus 2 incidence, as
HIV and syphilis prevalence were somewhat lower) is
puzzling and merits further study. The contrasting
result with the impact of the high-value conditional cash
transfers on the four curable STIs that were tested by
nucleic acid ampliﬁcation tests could point to the
importance of treatment seeking behaviour rather than
safer sexual practices. However, the interpretation of
herpes simplex virus 2 results is complicated by the fact
that most transmission occurs via asymptomatic shed-
ding by partners who may be otherwise low risk,
19 as
well as the fact that it can be transmitted even in the
c o n t e x to fa p p r o p r i a t ec o n d o mu s e .
20 Furthermore,
this study was not powered to directly examine HIV
conversion, thus implications for HIV prevention
remain speculative.
In order to study potential peer-effects, in randomly
selected subvillages, the probably of selection in the
intervention arm was 75% and in the other subvillages, it
was 25%. This might have led to baseline imbalances.
For this reason, we included subvillage indicator vari-
ables in the adjusted models. This might explain some of
the differences between the results from the unadjusted
and the adjusted models.
Finally, the results reported in this study are limited to
a 12-month experiment and cannot address the
sustainability of improvements in STI outcomes over
a longer period, particularly after the conditional cash
transfers have been discontinued. Nor can they address
the possibility of adverse consequences to the extent that
extrinsic incentives may reduce long-term intrinsic
motivation to engage in safe behaviours after incentives
are withdrawn. To address these questions, we will follow-
up with study participants 1 year following the end of the
intervention study, in the Spring of 2011, to assess
whether improved outcomes have been sustained, or
reversed, in the absence of a positive feedback mecha-
nism in the form of STI testing and conditional cash
transfers.
Generalisability
While these study results are important in showing that
the idea of using ﬁnancial incentives can be a useful tool
for preventing HIV and STI transmission, it remains an
initial study on a limited scale. Even though the study
site is fairly representative of rural and small town envi-
ronments in sub-Saharan Africa, this approach would
need to be replicated elsewhere and implemented on
a larger scale (in permutations requiring less adminis-
trative and laboratory capacity) before it could be
concluded that such conditional cash transfer
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HIV prevention strategy.
Interpretation
The results indicate that conditional cash transfers based
on negative results of periodic screenings for incident
STIsdan objectively measured marker for risky sexual
behaviourdare a potentially useful tool for STI and
possibly HIV prevention. The extraordinarily high social
and economic cost of the current HIV and AIDS crisis
suggests that prevention can be far cheaper than treat-
ment, thus motivating the continued search for innova-
tive and effective new prevention approaches, such as
conditional cash transfers or other ﬁnancial incentives.
The absence of signiﬁcant impacts at rounds 2 (month
4) and 3 (month 8) suggests that the impact of the
conditional cash transfer may take time to materialise,
perhaps because it is not easy to extricate oneself from
complicated sexual relationships, or perhaps because
participants needed time to become accustomed to
(and trust) the incentive mechanism. The comparison
between the impacts of the conditional cash transfer
intervention in the high-value conditional cash
transfer arm to that in the low-value conditional cash
transfer arm permits us to better understand at which
threshold conditional cash transfers can be effective as
an HIV and STI prevention tool. While the results
showed a signiﬁcant reduction in STI incidence in the
arm that was eligible for the $20 conditional cash
transfers every 4 months or up to $60 over 12 months, no
such reduction was found for the arm receiving the $10
conditional cash transfers every 4 months or up to $30
over 12 months. This distinction must be interpreted
with caution though because assignments were not
masked, hence individuals in the low-value conditional
cash transfer arm could have behaved differently than if
they were to receive the same incentive in the absence of
a higher conditional cash transfer arm. Both of these
amounts represent a meaningful proportion of house-
hold income in a country where gross domestic product
per capita was $440 in 2008, and particularly among our
study participants who had mean individual annual
earnings of approximately $250.
OTHER INFORMATION
Registration
This randomised control trial is registered at ClinicalTrials.
gov, study identiﬁer # NCT00922038.
Protocol
The study protocol was initially approved by the
University of California; Berkeley’s Institutional Review
Board (Committee for Protection of Human Subjects)
effective 17 December 2008; approval has been updated
numerous times since to reﬂect protocol amendments,
with the latest approval effective 11 October 2011. The
Ifakara Health Institute Institutional Review Board
initially approved the study on 24 July 2008. The latest
amended approval is from 11 February 2010. Tanzania’s
National Institute for Medical Research approved the
study 5 February 2009.
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